S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Progenics Pharmaceuticals Announces Third Quarter 2014 Financial Results|
|Progenics Pharmaceuticals Presents Long Term Follow-Up of Pivotal Phase 2 Trial of Azedra in Malignant Pheochromocytoma|
|Progenics Pharmaceuticals Sets Third Quarter Financial Results Call for November 7|
|Progenics Pharmaceuticals to Participate in Upcoming Conferences|
|Progenics Pharmaceuticals Announces Presentation at RSNA Annual Meeting|
|Phase 2 Data for Progenics' 1404 Imaging Agent Presented at EANM Congress|
|Progenics Receives $40 Million Milestone Following FDA Approval of RELISTOR for OIC Patients With Chronic Non-Cancer Pain|
|FDA Approves RELISTOR® Subcutaneous Injection for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-cancer Pain|
|BIND Therapeutics Appoints Hagop Youssoufian, M.Sc., M.D. as Chief Medical Officer|
Click above to view more mutual fund data and stats for pgnx - Progenics Pharmaceuticals Inc.